marstacimab
General
Pronunciation:
mar-stak--i-mab
Trade Name(s)
- Hympavsi
Ther. Class.
temporary class
antihemophilic agentsPharm. Class.
tissue factor pathway inhibitor antagonists
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Marstacimab." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580214/all/marstacimab.
Vallerand AHA, Sanoski CAC. Marstacimab. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580214/all/marstacimab. Accessed October 19, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Marstacimab. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580214/all/marstacimab
Vallerand AHA, Sanoski CAC. Marstacimab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 October 19]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580214/all/marstacimab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - marstacimab
ID - 3580214
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580214/all/marstacimab
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

